NEW YORK (GenomeWeb News) – Shares of Luminex and Sequenom both fell by double digits today following disappointing first-quarter financial reports on Thursday.

In mid-afternoon trade on Friday, shares of Luminex had fallen nearly 13 percent to $15.49 while those of Sequenom had dropped more than 16 percent to $5.08.

Luminex yesterday reported that its second-quarter revenues increased 14 percent to $27.8 million, but this did not meet analyst estimates of $29.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.